{"database": "lobbying", "table": "lobbying_activities", "rows": [[1583626, "65332d30-4a89-49e6-90e3-ce69c1bcb67d", "3A", "RED+BLUE STRATEGIES", 400693064, "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", 2014, "third_quarter", "MMM", "Regulations and policies that focus on Medicare Part C and D\n\nPolicies related to stopping prescription medication diversion and abuse\n\nIssues related to the creation of a biosimilar marketplace in the United States\n\nIssues related to home delivery of prescription drugs\n\nIssues related to Part D coverage for Medicare beneficiaries in hospice care", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2014-10-09T16:50:00.180000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1583626"], "units": {}, "query_ms": 29.190599045250565, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}